
Coffee Beats Microdosing, AI Socializes, and Cartels Vape Now?
Coffee Beats Microdosing, AI Socializes, and Cartels Vape Now?
Synthesizing information from multiple news sources, a recent Australian biopharma study by MindBio Therapeutics investigated the effects of microdosing LSD on major depressive disorder and found that a placebo outperformed the psychedelic in reducing symptoms over an eight-week period, contradicting earlier anecdotal reports that touted microdosing as a beneficial treatment for depression. This Phase 2B trial, involving 89 adult patients, challenges the previously perceived benefits of microdosing, suggesting its effects may be overstated, at least in addressing clinical depression.






















Discussion
Join the conversation
Be the first to comment